Teleflex (TFX) Projected to Post Quarterly Earnings on Thursday

Teleflex (NYSE:TFX) will likely be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Teleflex to post earnings of $3.86 per share and revenue of $813.24 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Teleflex Trading Up 3.2 %

NYSE TFX opened at $174.74 on Thursday. Teleflex has a one year low of $165.62 and a one year high of $253.06. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm’s fifty day moving average is $177.41 and its two-hundred day moving average is $208.26. The firm has a market cap of $8.12 billion, a PE ratio of 34.74, a P/E/G ratio of 1.65 and a beta of 1.16.

Analyst Ratings Changes

A number of research firms recently commented on TFX. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Royal Bank of Canada reduced their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Truist Financial dropped their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Mizuho lowered their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.